To our knowledge, pre-diagnostic serum EGFR and ErbB2 concentrations have not been studied in glioma, although it is known that elevated serum EGFR in samples taken at glioma diagnosis is associated with worse prognosis [39]. Here, ERBB2 is linked to central nervous system cancer.